-
Stable Yeast Expression of Exendin-4 for Type 2 Diabetes
2026-09-18
A 2024 Frontiers in Systems Biology study established chromosomally integrated Saccharomyces cerevisiae as a platform for producing Exendin-4, a GLP-1 receptor agonist used in type 2 diabetes research. Expression at the expected molecular size and confirmation by immunoassay support technical feasibility, while functional activity, recovery, formulation, and therapeutic equivalence remain to be demonstrated.
-
Fluoxetine HCl for Reproducible Cell Assays
2026-09-18
Fluoxetine HCl (SKU A2436) can help researchers standardize serotonergic cell and receptor workflows when solvent compatibility, storage, and endpoint interpretation are controlled. This scenario-based guide connects documented pharmacology with practical approaches for viability, proliferation, cytotoxicity, and motivation-related studies.
-
2'-O-Methyladenosine: From Signal to Strategy
2026-09-17
A thought-leadership guide to using 2'-O-Methyladenosine as a mechanistic probe, authentic analytical standard, and translational decision point. The article connects RNA modification biology with purine metabolism studies, matrix-aware UHPLC–MS/MS, nucleoside transport assays, and evidence-based experimental design while distinguishing analytical opportunity from clinical proof.
-
TIA1–CLSTN1 Splicing Axis in Breast Cancer Metastasis
2026-09-17
The reference study identifies a DAPK3–TIA1–CLSTN1 regulatory axis that connects aberrant exon 11 inclusion with epithelial-to-mesenchymal transition and breast cancer metastasis. Its splice-switching antisense oligonucleotides provide a mechanistically grounded strategy for suppressing pro-metastatic cell behavior, while the culture formulation highlights the need to control hydrocortisone as an experimental variable.
-
EZ Cap Cy5 mRNA: Designing Decision-Ready Assays
2026-09-16
EZ Cap Cy5 Firefly Luciferase mRNA enables orthogonal fluorescence and bioluminescence readouts for resolving delivery, intracellular trafficking, and functional translation. This guide connects product design with practical assay decisions and lessons from recent circular mRNA CAR-T research.
-
H-89 for PKA and cAMP Signaling Research
2026-09-15
H-89 is a practical cAMP-dependent protein kinase inhibitor for separating PKA-dependent signaling from downstream metabolic, transcriptional, and phenotypic responses. This guide translates recent Wnt–O-GlcNAcylation findings into controlled workflows for osteogenesis, cell proliferation assays, apoptosis research, and pathway troubleshooting.
-
PF-562271 HCl: FAK/Pyk2 Workflow Guide
2026-09-15
A practical guide to using PF-562271 HCl for reversible FAK/Pyk2 pathway interrogation, from phospho-signaling assays to migration and tumor-model studies. It also shows how radiopathomics findings can inform assay stratification without overstating translational evidence.
-
Molnupiravir Against Bourbon Virus: Mouse Study Insights
2026-09-14
Bamunuarachchi and colleagues show that molnupiravir can suppress Bourbon virus replication and disease in cell culture and a lethal mouse model. The study is notable for combining survival data with tissue viral burden, thrombocytopenia, immune-cell profiles, and liver and spleen pathology, while also testing treatment after infection.
-
Dabigatran Etexilate in Coagulation Research
2026-09-14
Build more interpretable thrombin, plasma, and platelet assays with Dabigatran etexilate, using concentration-response design and prodrug-aware controls. This workflow connects direct pathway interrogation with anticoagulant for atrial fibrillation research while addressing solubility, activation, and assay variability.
-
Parthenolide, ROS, and Apoptosis in Lymphoid Malignancies
2026-09-13
Jorge and colleagues show that parthenolide reduces metabolic activity across diverse B- and T-lineage malignancy models while linking this effect to oxidative stress, glutathione depletion, mitochondrial disruption, and apoptosis. The study’s multi-endpoint design illustrates why a resazurin-based cell viability assay is most informative when paired with flow-cytometric and gene-expression measurements.
-
Norovirus Co-opts NINJ1 for Selective Secretion
2026-09-12
The reference study shows that murine norovirus uses the membrane-rupture factor NINJ1 to release the viral immune-modulatory protein NS1 through an unconventional pathway. By combining CRISPR screening, cell biology, mutagenesis, and mouse infection models, the authors connect caspase-3 activity, NINJ1 oligomerization, and selective viral protein secretion.
-
Plant Protein Secretion: Protocols and pH Readouts
2026-09-12
The second edition of Plant Protein Secretion: Methods and Protocols updates experimental frameworks for analyzing conventional and unconventional secretion in plant cells. Its main contribution is methodological: it connects pathway-specific concepts, plant organelle biology, and reproducible stepwise procedures that can be adapted to trafficking, compartment identity, and intracellular pH studies.
-
DAPT (GSI-IX) in Human Sensory Neuron Assays
2026-09-11
DAPT (GSI-IX) connects γ-secretase inhibition with practical studies of Notch signaling, APP processing, cancer phenotypes, and human sensory-neuron biology. This guide explains how to introduce the compound into hiPSC-derived neuron workflows while separating validated findings from hypothesis-generating applications.
-
Tapuy Lees Protect Neurons in C. elegans Models
2026-09-11
Remucal et al. investigated Tapuy rice wine and its fermentation by-product, Tapuy lees, in Caenorhabditis elegans models of amyloid-β toxicity and dopaminergic neurodegeneration. The study combines behavioral, cellular, biochemical, and LC–MS/MS analyses, finding that both preparations were protective while lees showed the strongest antioxidant profile and overall neuroprotective potential.
-
Angiotensin II: Practical Research Protocols
2026-09-10
This guide provides a controlled workflow for using Angiotensin II in receptor, vascular, cellular, and animal experiments, with emphasis on preparation, dosing, storage, and assay controls. It should support research models of vascular signaling and remodeling, but it is not a substitute for assay-specific validation, medical dosing guidance, or diagnostic use.